chaetocin and Disease-Models--Animal

chaetocin has been researched along with Disease-Models--Animal* in 1 studies

Reviews

1 review(s) available for chaetocin and Disease-Models--Animal

ArticleYear
Chaetocin: A review of its anticancer potentials and mechanisms.
    European journal of pharmacology, 2021, Nov-05, Volume: 910

    Chaetocin is a natural metabolite product with various biological activities and pharmacological functions isolated from Chaetomium species fungi belonging to the thiodiketopyrazines. Numerous studies have demonstrated a wide range of antitumor activities of chaetocin in vitro and in vivo. Several studies have demonstrated that chaetocin suppresses the growth and proliferation of various tumour cells by regulating multiple signalling pathways related to tumour initiation and progression, inducing cancer cell apoptosis (intrinsic and extrinsic), enhancing autophagy, inducing cell cycle arrest, and inhibiting tumour angiogenesis, invasion, and migration. The antitumor effects and molecular mechanisms of chaetocin are reviewed and analysed in this paper, and the prospective applications of chaetocin in cancer prevention and therapy are also discussed. This review aimed to summarize the recent advances in the antitumor activity of chaetocin and to provide a rationale for further exploring the potential application of chaetocin in overcoming cancer in the future.

    Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Biological Products; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Chaetomium; Disease Models, Animal; Humans; Neoplasm Invasiveness; Neoplasms; Piperazines; Xenograft Model Antitumor Assays

2021